Other drugs for Ménière’s disease and other labyrinthine disorders (Formulary)

Ménière’s is a disease causing attacks of disabling dizziness associated with transient loss of hearing and tinnitus. Betahistine is used specifically for Ménière’s however is of no benefit in other sorts of imbalance.  For further information refer to Dizziness guidance.

BETAHISTINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 8mg, 16mg

Dosage:

Vertigo, tinnitus and hearing loss associated with Ménière’s disease, initially 16mg 3 times daily, maintenance 24 to 48mg daily in divided doses.

CINNARIZINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 15mg

Dosage:

Vestibular disorders, 30mg 3 times daily. Motion sickness, 30mg 2 hours before travel then 15mg every 8 hours during journey if necessary.

Editorial Information

Document Id: F089